Literature DB >> 6073833

Observations on nicotinic acid therapy in Hartnup disease.

P W Wong, A M Lambert, P M Pillai, P M Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6073833      PMCID： PMC2019890          DOI： 10.1136/adc.42.226.642

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  8 in total

1.  Hartnup disease.

Authors:  K HALVORSEN; S HALVORSEN
Journal:  Pediatrics       Date:  1963-01       Impact factor: 7.124

2.  The metabolic disorder in Hartnup disease.

Authors:  M D MILNE; M A CRAWFORD; C B GIRAO; L W LOUGHRIDGE
Journal:  Q J Med       Date:  1960-07

3.  Quantitative determination of tryptophan metabolites (via kynurenine) in biologic fluids.

Authors:  D COPPINI; C A BENASSI; M MONTORSI
Journal:  Clin Chem       Date:  1959-10       Impact factor: 8.327

4.  The spectrophotofluorometric determination of tryptophan in plasma and of tryptophan and tyrosine in protein hydrolysates.

Authors:  D E DUGGAN; S UDENFRIEND
Journal:  J Biol Chem       Date:  1956-11       Impact factor: 5.157

5.  The excretion of amino acids by the human; a quantitative study with ion-exchange chromatography.

Authors:  D F EVERED
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

6.  Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features.

Authors:  D N BARON; C E DENT; H HARRIS; E W HART; J B JEPSON
Journal:  Lancet       Date:  1956-09-01       Impact factor: 79.321

7.  The fluorimetric estimation of N1-methylnicotinamide and its differentiation from coenzyme.

Authors:  K J CARPENTER; E KODICEK
Journal:  Biochem J       Date:  1950-04       Impact factor: 3.857

8.  BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. I. RESULTS OF INTRAVENOUS AND ORAL TRYPTOPHAN LOADING TESTS IN A CASE OF HARTNUP DISEASE.

Authors:  P DELAEY; C HOOFT; J TIMMERMANS; J SNOECK
Journal:  Ann Paediatr       Date:  1964
  8 in total
  5 in total

1.  Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinico-pathological case study.

Authors:  K Schmidtke; W Endres; A Roscher; H Ibel; N Herschkowitz; C Bachmann; E Plöchl; H B Hadorn
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

2.  Hartnup disease.

Authors:  K P Nair; B S Rao
Journal:  Indian J Pediatr       Date:  1971-09       Impact factor: 1.967

3.  Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.

Authors:  A J Jonas; I J Butler
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Cellular transport of L-histidine in Hartnup disease.

Authors:  S Halvorsen; O Hygstedt; R Jagenburg; O Sjaastad
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

5.  Accurate discrimination of Hartnup disorder from other aminoacidurias using a diagnostic ratio.

Authors:  H A Haijes; Hubertus C M T Prinsen; Monique G M de Sain-van der Velden; Nanda M Verhoeven-Duif; Peter M van Hasselt; Judith J M Jans
Journal:  Mol Genet Metab Rep       Date:  2019-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.